By David Wild
Originally published by our sister publication, Gastroenterology & Endoscopy News
The use of 5-aminosalicylic acid significantly increases the risk for Clostridioides difficile infection in pediatric patients with inflammatory bowel disease, according to a new meta-analysis.
There is scant literature and conflicting findings on CDI risk factors in the pediatric IBD population according to the investigators. For example, antibiotic use in pediatric patients has shown mixed